The Oncogenic 70Z Cbl Mutation Blocks the Phosphotyrosine Binding Domain-Dependent Negative Regulation of ZAP-70 by c-Cbl in Jurkat T Cells

ABSTRACT T-cell receptor (TCR) engagement results in the activation of Src family (Lck and Fyn) and ZAP-70 protein tyrosine kinases, leading to tyrosine phosphorylation of multiple cellular substrates including the complex adapter protein c-Cbl. Moreover, Cbl is tyrosine phosphorylated upon engagement of growth factor receptors, cytokine receptors, and immunoreceptors and functions as a negative regulator of tyrosine kinase signalling pathways. Cbl associates via its phosphotyrosine binding (PTB) domain to the ZAP-70 pY292 negative regulatory phosphotyrosine. We recently demonstrated that the oncogenic Cbl mutant, 70Z Cbl, requires its PTB domain to upregulate NFAT in unstimulated Jurkat T cells. Here, we demonstrate that kinase-dead but not wild-type forms of Fyn, Lck, and ZAP-70 block 70Z Cbl-mediated NFAT activation. Moreover, 70Z Cbl does not upregulate NFAT in the ZAP-70-deficient P116 Jurkat T-cell line. The requirement for Fyn, Lck, and ZAP-70 is not due to tyrosine phosphorylation of 70Z Cbl, as mutation of all tyrosines in, or deletion of, the C-terminal region of 70Z Cbl (amino acids 655 to 906) blocks 70Z Cbl tyrosine phosphorylation but enhances 70Z Cbl-mediated NFAT activation. Further, 70Z Cbl does not cooperate with ZAP-70 Y292F to upregulate NFAT, indicating that 70Z Cbl and ZAP-70 do not activate parallel signalling pathways. Finally, the upregulation of NFAT observed upon ZAP-70 overexpression is blocked by Cbl in a PTB domain-dependent manner. We conclude that oncogenic 70Z Cbl acts as a dominant negative to block the PTB domain-dependent negative regulatory role of endogenous Cbl on ZAP-70, leading to constitutive ZAP-70 signalling and activation of transcription factors.

[1]  L. Samelson,et al.  T cell antigen-receptor signal transduction. , 1999, Current opinion in immunology.

[2]  Michael J. Eck,et al.  Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase , 1999, Nature.

[3]  P. Paik,et al.  Activation of Nuclear Factor of Activated T Cells-(NFAT) and Activating Protein 1 (AP-1) by Oncogenic 70Z Cbl Requires an Intact Phosphotyrosine Binding Domain but Not Crk(L) or p85 Phosphatidylinositol 3-Kinase Association* , 1999, The Journal of Biological Chemistry.

[4]  Yun-Cai Liu,et al.  Dual Regulation of T Cell Receptor-mediated Signaling by Oncogenic Cbl Mutant 70Z* , 1999, The Journal of Biological Chemistry.

[5]  H. Band,et al.  Cbl-mediated Negative Regulation of the Syk Tyrosine Kinase , 1998, The Journal of Biological Chemistry.

[6]  M. Naramura,et al.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  W. Seaman,et al.  DAP12-mediated Signal Transduction in Natural Killer Cells , 1998, The Journal of Biological Chemistry.

[8]  D. Birnbaum,et al.  A third human CBL gene is on chromosome 19. , 1998, International journal of oncology.

[9]  Z. Kam,et al.  c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.

[10]  R. Geahlen,et al.  Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling. , 1998, Journal of immunology.

[11]  E. Roos,et al.  ZAP-70 Tyrosine Kinase Is Required for LFA-1–dependent T Cell Migration , 1998, The Journal of cell biology.

[12]  S. Amigorena,et al.  syk protein tyrosine kinase regulates Fc receptor γ‐chain‐mediated transport to lysosomes , 1998 .

[13]  D. Bowtell,et al.  Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice , 1998, Molecular and Cellular Biology.

[14]  A. Sorkin,et al.  Endocytosis and intracellular sorting of receptor tyrosine kinases. , 1998, Frontiers in bioscience : a journal and virtual library.

[15]  B. Druker,et al.  The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Geisler,et al.  Two distinct pathways exist for down-regulation of the TCR. , 1998, Journal of immunology.

[17]  T. Pawson,et al.  The Syk Protein Tyrosine Kinase Is Essential for Fcγ Receptor Signaling in Macrophages and Neutrophils , 1998, Molecular and Cellular Biology.

[18]  K. Vuori,et al.  Oncogenic forms of Cbl abrogate the anchorage requirement but not the growth factor requirement for proliferation , 1998, Oncogene.

[19]  A. Lenferink,et al.  Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.

[20]  G. Koretzky,et al.  Adaptor proteins in lymphocyte antigen-receptor signaling. , 1998, Current opinion in immunology.

[21]  M. Deckert,et al.  Coordinated Regulation of the Tyrosine Phosphorylation of Cbl by Fyn and Syk Tyrosine Kinases* , 1998, The Journal of Biological Chemistry.

[22]  W. Langdon,et al.  Fyn, Yes, and Syk Phosphorylation Sites in c-Cbl Map to the Same Tyrosine Residues That Become Phosphorylated in Activated T Cells* , 1998, The Journal of Biological Chemistry.

[23]  V. Tybulewicz Analysis of antigen receptor signalling using mouse gene targeting. , 1998, Current opinion in cell biology.

[24]  R. Abraham,et al.  Genetic Evidence for Differential Coupling of Syk Family Kinases to the T-Cell Receptor: Reconstitution Studies in a ZAP-70-Deficient Jurkat T-Cell Line , 1998, Molecular and Cellular Biology.

[25]  L. Cantley,et al.  The Cbl Phosphotyrosine-binding Domain Selects a D(N/D)XpY Motif and Binds to the Tyr292Negative Regulatory Phosphorylation Site of ZAP-70* , 1997, The Journal of Biological Chemistry.

[26]  W. Langdon,et al.  Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl , 1997, Oncogene.

[27]  B. Rellahan,et al.  Cbl-mediated Regulation of T Cell Receptor-induced AP1 Activation , 1997, The Journal of Biological Chemistry.

[28]  L. Hicke Ubiquitin‐dependent internalization and down‐regulation of plasma membrane proteins , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  J. Ashwell,et al.  Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation. , 1997, Immunity.

[30]  A. DeFranco,et al.  A Critical Role for Syk in Signal Transduction and Phagocytosis Mediated by Fcγ Receptors on Macrophages , 1997, The Journal of experimental medicine.

[31]  H. Band,et al.  Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity , 1997, Molecular and cellular biology.

[32]  D. Bowtell,et al.  D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites , 1997, Oncogene.

[33]  W. Langdon,et al.  EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene , 1997, Oncogene.

[34]  M. Turner,et al.  The Fc receptor γ‐chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen , 1997, The EMBO journal.

[35]  L. Samelson,et al.  The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. , 1997, Science.

[36]  J. Gorvel,et al.  Tyrosine and serine protein kinase activities associated with ligand-induced internalized TCR/CD3 complexes. , 1997, Journal of immunology.

[37]  N. Hynes,et al.  ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.

[38]  U. Banerjee,et al.  Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development , 1997, Molecular and cellular biology.

[39]  Y. Yazaki,et al.  Antisense Repression of Proto-oncogene c-Cbl Enhances Activation of the JAK-STAT Pathway but Not the Ras Pathway in Epidermal Growth Factor Receptor Signaling* , 1997, The Journal of Biological Chemistry.

[40]  W. Langdon,et al.  Ras-dependent, Ca2+-stimulated Activation of Nuclear Factor of Activated T Cells by a Constitutively Active Cbl Mutant in T Cells* , 1997, The Journal of Biological Chemistry.

[41]  A. Weiss,et al.  Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70 , 1996, Molecular and cellular biology.

[42]  J. Kinet,et al.  Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells , 1996, The Journal of experimental medicine.

[43]  L. Samelson,et al.  Regulation of the Association of p120cbl with Grb2 in Jurkat T Cells* , 1996, The Journal of Biological Chemistry.

[44]  H. Band,et al.  A Novel Phosphotyrosine-binding Domain in the N-terminal Transforming Region of Cbl Interacts Directly and Selectively with ZAP-70 in T Cells* , 1996, The Journal of Biological Chemistry.

[45]  T. Kurosaki,et al.  Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function , 1996, Molecular and cellular biology.

[46]  K. Sakaguchi,et al.  Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity , 1996, Molecular and cellular biology.

[47]  P. Freemont,et al.  The RING finger domain: a recent example of a sequence-structure family. , 1996, Current opinion in structural biology.

[48]  J. Northrop,et al.  Characterization of the roles of SH2 domain-containing proteins in T-lymphocyte activation by using dominant negative SH2 domains , 1996, Molecular and cellular biology.

[49]  Y. Yarden,et al.  Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. , 1996, Oncogene.

[50]  G. Carpenter,et al.  All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*) , 1996, The Journal of Biological Chemistry.

[51]  S. Corvera,et al.  Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin , 1996, The Journal of cell biology.

[52]  A. Weiss,et al.  Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling , 1996, The Journal of experimental medicine.

[53]  W. Langdon,et al.  c-Cbl Is Transiently Tyrosine-phosphorylated, Ubiquitinated, and Membrane-targeted following CSF-1 Stimulation of Macrophages (*) , 1996, The Journal of Biological Chemistry.

[54]  P. Sternberg,et al.  Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl , 1995, Science.

[55]  R. Aebersold,et al.  Activating and Inhibitory Mutations in Adjacent Tyrosines in the Kinase Domain of ZAP-70 (*) , 1995, The Journal of Biological Chemistry.

[56]  K. Robbins,et al.  Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. , 1995, Oncogene.

[57]  R. Johnson,et al.  Activation of ZAP‐70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. , 1995, The EMBO journal.

[58]  W. Langdon,et al.  Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. , 1994, The EMBO journal.

[59]  L. Samelson,et al.  The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. , 1994, The Journal of biological chemistry.

[60]  M. Zerial,et al.  Association of Rap1a and Rap1b proteins with late endocytic/phagocytic compartments and Rap2a with the Golgi complex. , 1994, Journal of cell science.

[61]  R. Klausner,et al.  Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif , 1994, Molecular and cellular biology.

[62]  A. Hata,et al.  Tyrosine kinases Lyn and Syk regulate B cell receptor‐coupled Ca2+ mobilization through distinct pathways. , 1994, The EMBO journal.

[63]  A. Weiss,et al.  Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. , 1994, Science.

[64]  R. Abraham,et al.  Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. , 1993, The Journal of biological chemistry.

[65]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[66]  W. Langdon,et al.  The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. , 1991, Oncogene.

[67]  E. Stanley,et al.  CSF‐1 stimulated multiubiquitination of the CSF‐1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins , 1999, Journal of cellular biochemistry.

[68]  J. Bonifacino,et al.  Ubiquitin and the control of protein fate in the secretory and endocytic pathways. , 1998, Annual review of cell and developmental biology.

[69]  S. Amigorena,et al.  syk protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes. , 1998, The EMBO journal.

[70]  J. Borst,et al.  The Cbl family of signal transduction molecules. , 1997, Critical reviews in oncogenesis.

[71]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.